Results 211 to 220 of about 1,312,286 (300)

Process development priorities for scaling up direct microbial conversion of sugars into value‐added biochemicals

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The study identified process development priorities toward the feasible production of five value‐added biochemicals in a sugarcane biorefinery based on achievable bioconversion performances. Multiple process scenarios using A‐molasses as feedstock were simulated in Aspen Plus® via direct microbial conversions.
Manasseh K. Sikazwe, Jeanne Louw, Johann F. Görgens   +2 more
wiley   +1 more source

Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate Cancer. [PDF]

Cancer Med
Faraj KS, Oerline M, Kaufman SR, Dall C, Srivastava A, Liu X, Caram MEV, Shahinian VB, Hollenbeck BK.   +8 more
europepmc   +1 more source

Market potential of biobased chemicals: a qualitative network analysis of adoption dynamics in South Africa’s bioeconomy

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The premise of a bioeconomy is the replacement of nonrenewable and unsustainable fossil‐derived resources and associated technologies with more sustainable alternatives. The adoption of biobased chemicals contributes toward the growth of a bioeconomy and is dependent on market and industry requirements.
Prisha Mandree, George Alex Thopil, Santosh Ramchuran   +2 more
wiley   +1 more source

The crisis we are not naming: The psychology of capitalism. [PDF]

Br J Soc Psychol
Bettache K.
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

'Exosomes': The Hype, the Chasm, and Beyond. [PDF]

J Extracell Biol
Zarovni N, Glebov K.
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Fatty Acid Profile and Hazard Index of Ready-to-Eat Foods Available in the Market: A Risk Survey. [PDF]

Int J Prev Med
Moslemi M, Abedi AS, Shahbazpour N, Bahramian G, Ferdousi R, Beladian Behbahan SE.   +5 more
europepmc   +1 more source

Community pharmacists' practices and perspectives on deprescribing high‐risk psychotropic medicines: National survey findings

British Journal of Clinical Pharmacology, EarlyView.
Aim To explore the practices, confidence and perspectives of community pharmacists in deprescribing high‐risk psychotropic medicines, including opioid analgesics, benzodiazepine, gabapentinoids and medicinal cannabis. Methods An anonymous, cross‐sectional national online survey was conducted between January and April 2025 among Australian community ...
Monica Jung, Louisa Picco, Aili V. Langford, Rose Laing, Jana Dostal, Suzanne Nielsen   +5 more
wiley   +1 more source

Wildfires have created instability within risk transfer markets. Here's a path forward. [PDF]

Proc Natl Acad Sci U S A
Thompson MP, Calkin DE, MacGregor DM, Young BA, Barrett K, Fischer EC, Johnson JV.   +6 more
europepmc   +1 more source